Kristina Rasmussen

Medicine & Life Sciences

1. Congenital Hyperinsulinism 100%
2. Fetal Erythroblastosis 93%
3. Fecal Microbiota Transplantation 93%
4. Lymphoma, Large B-Cell, Diffuse 72%
5. Age Factors 71%
6. Stem Cell Transplantation 67%
7. Hemostasis 64%
8. Rho(D) Immune Globulin 58%
9. Lymphoma 53%
10. Thrombosis 49%
11. Immunoglobulin G 48%
12. Hospitalization 47%
13. Hyperbilirubinemia 44%
14. Laboratory Personnel 43%
15. Donor Selection 41%
16. Hemorrhage 41%
17. Transplants 40%
18. European Union 36%
19. Survival 35%
20. Blood Donors 32%
21. Gastrointestinal Microbiome 31%
22. Anemia 30%
23. Fetomaternal Transfusion 30%
24. Documentation 30%
25. Cost-Benefit Analysis 27%
26. Registries 25%
27. Tissue Donors 25%
28. Healthy Volunteers 22%
29. Guidelines 20%
30. Costs and Cost Analysis 20%
31. Behavior Therapy 19%
32. Salvage Therapy 19%
33. Safety 18%
34. Bile 18%
35. Mothers 17%
36. Patient Rights 17%
37. iminodiacetic acid 15%
38. Progression-Free Survival 14%
39. Proportional Hazards Models 14%
40. Newborn Infant 14%
41. Medical Records 13%
42. RHO(D) antibody 12%
43. Coombs Test 12%
44. Poisons 11%
45. Hepatobiliary Elimination 11%
46. Y Chromosome 11%
47. Whole Exome Sequencing 10%
48. Therapeutics 10%
49. Cholestasis 10%
50. Positron Emission Tomography Computed Tomography 10%